Centre To Convert 2,000 Agri Societies Into Jan Aushadhi Kendras

New Delhi : The Union government has identified 2,000 primary agricultural credit societies (PACS) to serve as Pradhan Mantri Bhartiya Jan Aushadhi Kendras, which are low-cost pharmacies selling unbranded medicines, which officials said would bolster last-mile health care delivery.

“One thousand centres will start functioning by August and the next 1,000 by December this year,” an official said, declining to be named. The move follows a plan to diversify these farm-service points and an agreement overseen by home minister Amit Shah and health minister Mansukh Mandaviya.

The cooperation ministry, also headed by Shah, is currently ramping up a drive to digitize PACS, which act as last-mile financial institutions for millions of farmers, which will enable them to diversify their business activities.

The Pradhan Mantri Bhartiya Janaushadhi Pariyojana was launched by the chemicals and fertilizers ministry headed by Mandaviya in November 2008 to make quality generic medicines available at affordable prices. These dispensing facilities sell generic drugs that are 50-90% cheaper than branded drugs.

The Centre has rolled out changes to revamp the cooperative sector. At the heart of the overhaul is the plan to digitise PACS. India has nearly 800,000 cooperatives with a total membership base of about 290 million individuals, including banks, sugar mills and businesses, such as fertilizer-maker IFFCO and milk brand Amul. Cooperatives are collectives jointly owned by participating members who share profits and losses.

To be eligible to dispense drugs under the scheme, a primary cooperative society needs at least 120 sq. ft space, either privately owned or rented. The application fee for a Jan Aushadhi Kendra is ₹5,000. Women entrepreneurs, differently abled citizens, and scheduled castes and tribes get priority under special categories. All fees are waived off for applications from the special category, the official said.

  • Related Posts

    Indian Pharma Majors Plan to Invest in US

    National Harbor (US): Top Indian pharmaceutical companies, including at least three from Hyderabad, are all set to announce major investments to set up new facilities in the United States during…

    Emcure Pharmaceuticals Q4 net profit rises 24% to ₹243.74 cr

    Emcure Pharmaceuticals Ltd on Tuesday reported a 24 per cent increase in consolidated net profit at ₹243.74 crore in the fourth quarter ended March 2026 on the back of robust…

    Leave a Reply

    Your email address will not be published. Required fields are marked *

    You Missed

    Indian Pharma Majors Plan to Invest in US

    Indian Pharma Majors Plan to Invest in US

    Emcure Pharmaceuticals Q4 net profit rises 24% to ₹243.74 cr

    Emcure Pharmaceuticals Q4 net profit rises 24% to ₹243.74 cr

    Fake Cancer Drug Racket: Delhi HC Grants Bail, Flags Gaps in ED Probe

    Fake Cancer Drug Racket: Delhi HC Grants Bail, Flags Gaps in ED Probe

    A SSi Mantra fame Robotic Telesurgery Champion pulls off another Spectacular Intercontinental

    A SSi Mantra fame Robotic Telesurgery Champion pulls off another Spectacular Intercontinental

    National Pharmaceutical Pricing Authority notifies retail price of 42 new drugs

    National Pharmaceutical Pricing Authority notifies retail price of 42 new drugs

    World’s First Malaria Treatment for Newborns and Young Infants Receives WHO Prequalification

    World’s First Malaria Treatment for Newborns and Young Infants Receives WHO Prequalification